Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Ownership 2026-05-25
MacNaught, Hugh bought +$15k
Insider trading – 2026-05-25
1 insider · +$15k net
Transactions 2026-05-22 Financing
Ventripoint Announces Closing of $308,030 Non-Brokered Units Private Placement
News release - English.pdf
Transactions 2026-05-22 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-05-19 Financing
Ventripoint Issues Shares for Payment of Debenture Interest
News release - English.pdf
News 2026-05-04
Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
News release - English.pdf
Results 2026-05-01
Annual MD&A - English.pdf
Results 2026-05-01
Audited annual financial statements – English.pdf
News 2026-04-28
Ventripoint's VMS+™ 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc.
News release - English.pdf
Transactions 2026-04-22 Financing
Ventripoint Issue Shares for Payment of Debenture Interest
News release - English.pdf
News 2026-04-20
Ventripoint's VMS™ 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential
News release - English.pdf
News 2026-04-01
Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group
News release - English.pdf
News 2026-03-17
Ventripoint Partners with First Light Health to Bring AI-Powered Cardiac Diagnostics to Indigenous and Remote Communities
News release - English.pdf
News 2026-03-04
Report of exempt distribution (45-106F1).pdf
Transactions 2026-03-04 Financing
Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions
News release - English.pdf
News 2026-03-03
Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California
News release - English.pdf
Transactions 2026-02-11 Financing
Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions
News release - English.pdf
News 2026-01-30
Report of exempt distribution (45-106F1).pdf
Transactions 2026-01-28 Financing
Ventripoint Issues Shares for Debt Settlement and Awards Option Grants
News release - English.pdf
News 2026-01-23
Report of exempt distribution (45-106F1).pdf
Transactions 2026-01-19 Financing
Ventripoint Announces Closing of Non-Brokered Units Private Placement
News release - English.pdf
Transactions 2026-01-16 Financing
Ventripoint Diagnostics Ltd. Issues Shares for Payment of Debenture Interest
News release - English.pdf
Transactions 2026-01-07 Financing
Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand
News release - English.pdf
Transactions 2025-12-30 Financing
Ventripoint Announces Non-Brokered Units Private Placement
News release - English.pdf
News 2025-12-18
Ventripoint Diagnostics Announces Collaboration with Summit Sciences
News release - English.pdf
Transactions 2025-12-18 Financing
Ventripoint to Issue Shares for Payment of Debenture Interest
News release - English.pdf
News 2025-12-12
Ventripoint Unveils a Global Model for A.I.- Enhanced Heart Care Through Partnership With the Nisga'a Valley Health Authority
News release - English.pdf
Results 2025-11-28 Financials
Interim MD&A - English.pdf
Results 2025-11-28 Financials
Interim financial statements/report – English.pdf
News 2025-11-06
News release - English.pdf
News 2025-10-29
News release - English.pdf
News 2025-10-24
News release - English.pdf
News 2025-10-22
Report of exempt distribution (45-106F1).pdf
News 2025-10-14
Material change report - English.pdf
News 2025-10-14
News release - English.pdf
News 2025-10-03
News release - English.pdf
News 2025-09-19
News release - English.pdf
News 2025-09-08
Report of exempt distribution (45-106F1).pdf
News 2025-09-08
Report of exempt distribution (45-106F1) (amended).pdf
News 2025-09-03
Material change report - English.pdf
News 2025-09-03
News release - English.pdf
Results 2025-08-29 Financials
Interim MD&A - English.pdf
Results 2025-08-29 Financials
Interim financial statements/report – English.pdf
News 2025-08-28
Report of exempt distribution (45-106F1).pdf
News 2025-08-26
Material change report - English.pdf
News 2025-08-26
News release - English.pdf
News 2025-08-18
News release - English.pdf
News 2025-08-15
News release - English.pdf
News 2025-07-28
News release - English.pdf
News 2025-07-11
News release - English.pdf
News 2025-06-30
News release - English.pdf
News 2025-06-17
News release - English.pdf
News 2025-06-17
News release - English.pdf
News 2025-06-17
News release - English.pdf